GenomesDAO logo
WebsiteSushiSwap Miso Launchpad

GenomesDAO (GENE)

IDO

GenomesDAO is a genomic data security company that democratizes and decentralizes genomics in Healthcare. Users make passive income on their DNA stored in AMD SEV-ES, vaults using DeFi Protocol governance and DAO membership is only achieved by staking GENE, the deflationary GenomesDAO utility token.

IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Overview

Project industryHealth & Medicine
Product typeOrganization
FoundedUnited Kingdom
WhitepaperGenomesDAO White Paper Open

What is GenomesDAO

Genomes.io is a genomic data security company co-founded by Dr Mark Hahnel and Aldo de Pape in 2018. We are a UK-registered company and operate from London, UK. The project strives to meet the increasing expectations of research organizations, institutions as well as customers for the security of genomic data and the quality of research workflow. In order to increase the democratization and decentralization of genomic studies, we focus on combining cutting-edge technologies such as AMD’s SEV, blockchain and decentralized finance.

Details

IDO (SushiSwap Miso Launchpad): Nov 16, 2021 - Nov 16, 2021
Token supply: 1,000,000,000 GENE
Total tokens for sale: 300,000,000 GENE
Raised: 100 ETH

Legal

Blockchain Platform: Ethereum
Registration country: United Kingdom
Registration year: 2018
Office address: 30 Caledonian Road, London, London N1 9DT, GB

Token info

Ticker: GENE
Type: Utility-token
Token distribution:
30% - IDO
30% - Liquidity
6% - Pre Seed
5.66% - Folks who supported GenomesDAO over the last 3 years
8.34% - Marketing
10% - Team
10% - Locked

GenomesDAO Roadmap

1
16th November 2021

MISO Public $GENE Sale

2
2021

NFT Project Launch

3
Q4 2021

Company Operations

  • Scale up Team
  • Apply tokenomics across platform
4
2022

10,000 Genomes is our AMD SEV-ES vaults
Brokerage of Data to pharma - aka - making passive income for our users
Launch of GenomesDAO secure Organisational Platform (Rare Disease Charities etc)
Expansion of Tests Available - Open API to 3rd Parties

Project team

Aldo De Pape
Aldo De Pape
CEO
Aldo De Pape linkedin
Dr. Mark Hahnel
Dr. Mark Hahnel
Chief Scientist
Dr. Mark Hahnel linkedin
Micky Socaci
Micky Socaci
Lead Developer
Louis Gooden
Louis Gooden
Analyst
Vlad Morar
Vlad Morar
Software Developer
Krisid Misso
Krisid Misso
Project Manager
Deivis Kuqo
Deivis Kuqo
UX/UI Designer
Xheni Haxhiu
Xheni Haxhiu
Software Developer
Axhem Shahaj
Axhem Shahaj
Software Developer
Calin G
Calin G
Blockchain Developer
Xhuljan Teleku
Xhuljan Teleku
Front-end Developer
Bastian Greshalke
Bastian Greshalke
Lead Bioinformatician

Advisors

Praneeth Srikanti
Praneeth Srikanti
Investment Principle at Consensys Labs
Prof Hugh Montgomerey
Prof Hugh Montgomerey
Director of UCL Institute for Human Health and Performance
Joe Stringer
Joe Stringer
Managing Partner of TenX Health

Social media

GenomesDAO web-siteGenomesDAO MediumGenomesDAO InstagramGenomesDAO LinkedInGenomesDAO TwitterGenomesDAO FacebookGenomesDAO Discord

Increase your Conversion Rate

Add our widget to your website and make an announcement of the listing in your social media

Horizontal
Square
Light
Dark
Height: 50 px
Width: 160 px

Leave a Reply

Your email address will not be published. Required fields are marked *

Sponsored Crypto Projects